Amide derivatives of glycolic acid: introducing a new class of anti tuberculosis agents
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: KOBARFARD, Farzad (Shaheed Beheshti School of Pharmacy, Medicinal Chemistry, Tehran, Iran)
- Co-author(s): Daryai (Tehran School of Pharmacy, Iran)
Khalaj (Tehran School of Pharmacy, Iran)
Tuberculosis kills about two million people each year and nearly one-third of the world's population is currently infected with it. On the other hand, due to increasing resistance to the present chemotherapeutic agents, finding new drugs against Mycobacterium tuberculosis is a necessity.
Cell wall of Mycobacterium has been one of the most.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.